These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24628806)

  • 1. Commentary on 'accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimized multi-arm phase I/II trial design'.
    Dixon D
    Trials; 2014 Mar; 15():76. PubMed ID: 24628806
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.
    Richert L; Doussau A; Lelièvre JD; Arnold V; Rieux V; Bouakane A; Lévy Y; Chêne G; Thiébaut R;
    Trials; 2014 Feb; 15():68. PubMed ID: 24571662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand.
    Thapinta D; Jenkins RA; Morgan PA; Chiu J; Boenim W; Bussaratid V; Chaddic C; Naksrisook S; Phonrat B; Sirijongdee N; Sornsathapornkul P; Sontirat A; Srisaengchai P; Suwanarach C; Wongkamhaeng S; Brown AE; Khamboonruang C; Nitayaphan S; Pitisuttithum P; Thongchareon P;
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):503-13. PubMed ID: 12154341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical evaluation of HIV vaccines in early clinical trials.
    Moodie Z; Rossini AJ; Hudgens MG; Gilbert PB; Self SG; Russell ND
    Contemp Clin Trials; 2006 Apr; 27(2):147-60. PubMed ID: 16426900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
    Thapinta D; Jenkins RA
    Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-cardiac echocardiography guided cardioversion to help interventional procedures (ICE-CHIP) study: study design and methods.
    Rao HB; Saksena S; Mitruka R;
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():31-6. PubMed ID: 16133853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data released on immune therapy.
    AIDS Patient Care STDS; 2005 Oct; 19(10):699. PubMed ID: 16232055
    [No Abstract]   [Full Text] [Related]  

  • 9. New HIV/AIDS vaccine enters phase II trials.
    Ahmad K
    Lancet Infect Dis; 2005 Mar; 5(3):138. PubMed ID: 15779123
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating cumulative probabilities from incomplete longitudinal binary responses with application to HIV vaccine trials.
    Hudgens MG
    Stat Med; 2003 Feb; 22(3):463-79. PubMed ID: 12529875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethical elements in the development of vaccines against HIV/AIDS].
    Molina CN
    Sidahora; 2001 Oct; ():14-6. PubMed ID: 11776246
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV immunology: what lessons can we learn from recent vaccine trials?
    Kelleher P
    J HIV Ther; 2010 Mar; 15(1):2-5. PubMed ID: 21180231
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on 'Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design' by Satoshi Morita and Junichi Sakamoto. Pharmaceutical Statistics.
    Hossain MM; Chen Z
    Pharm Stat; 2012; 11(3):267-8. PubMed ID: 22451454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania.
    Tarimo EA; Thorson A; Kohi TW; Bakari M; Mhalu F; Kulane A
    PLoS One; 2011 Feb; 6(2):e14619. PubMed ID: 21358826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials.
    Farrington P; Miller E
    Methods Mol Med; 2003; 87():335-52. PubMed ID: 12958466
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/II HIV vaccine trials.
    Mbunda T; Bakari M; Tarimo EA; Sandstrom E; Kulane A
    Glob Health Action; 2014; 7():22853. PubMed ID: 24572007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
    WHO/UNAIDS/IAVI International Expert Group
    AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccines. Viral envelope fails to deliver?
    Bolognesi DP; Matthews TJ
    Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of placebos in Phase 1 preventive HIV vaccine clinical trials.
    Huang Y; Karuna ST; Janes H; Frahm N; Nason M; Edlefsen PT; Kublin JG; Corey L; McElrath MJ; Gilbert PB
    Vaccine; 2015 Feb; 33(6):749-52. PubMed ID: 25454855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.